The computational pathology technology provider has added $25m to a round co-led by Johnson & Johnson Innovation – JJDC.
US-based diagnostics software provider Paige increased a series C round co-led by medical products group Johnson & Johnson to $125m yesterday with funding from investment firm KKR.
The company raised the first $100m in January this year, in a tranche co-led by Johnson & Johnson subsidiary Johnson & Johnson Innovation – JJDC and life sciences investment firm Casdin Capital.
KKR has now been identified as a co-lead for the round, which includes Catalio Capital Management along with unnamed existing…
